Home LiteratureArticle Details
PMID: 7972127 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.

Broder CC, Earl PL, Long D, Abedon ST, Moss B, Doms RW

Abstract

A majority of monoclonal antibodies (mAbs) raised against soluble oligomeric human immunodeficiency virus type 1 isolate IIIB (HIV-1IIIB) envelope (env) glycoprotein reacted with conformational epitopes within the gp120 or gp41 subunits. Of 35 mAbs directed against gp41, 21 preferentially reacted with oligomeric env. A subset of these mAbs reacted only with env oligomers (oligomer-specific mAbs). In contrast, only 1 of 27 mAbs directed against the gp120 subunit reacted more strongly with env oligomers than with monomers, and none were oligomer-specific. However, 50% of anti-gp120 mAbs preferentially recognized monomeric env, suggesting that some epitopes in gp120 are partially masked or altered by intersubunit contacts in the native env oligomer. Two mAbs to oligomer-dependent epitopes in gp41 neutralized HIV-1IIIB and HIV-1SF2, and binding of these mAbs to env was blocked by preincubation with HIV-1-positive human serum. Thus, immunization with soluble, oligomeric env elicits antibodies to conserved, conformational epitopes including a newly defined class of neutralizing antibodies that bind to oligomer-specific epitopes in gp41, and may also minimize the production of antibodies that preferentially react with monomeric env protein.

MeSH Terms
Animals Antibodies, Monoclonal/immunology Epitope Mapping HIV Antigens/chemistry HIV Envelope Protein gp120/chemistry,immunology HIV Envelope Protein gp41/chemistry,immunology HIV-1/immunology Humans Macromolecular Substances Mice Neutralization Tests Protein Conformation Viral Envelope Proteins/chemistry,immunology
Chemicals
Antibodies, Monoclonal HIV Antigens HIV Envelope Protein gp120 HIV Envelope Protein gp41 Macromolecular Substances Viral Envelope Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Broder C C
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Earl P L
Long D
Abedon S T
Moss B
Doms R W
References (40)
40 references, click to expand
  1. Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.
    J Immunol. 1990 Jun 15;144(12):4641-7 PMID: 1693639
  2. C-terminal fragments of gp120 and synthetic peptides from five HTLV-III strains: prevalence of antibodies to the HTLV-III-MN isolate in infected individuals.
    AIDS Res Hum Retroviruses. 1990 Mar;6(3):307-16 PMID: 2340200
  3. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody.
    J Virol. 1991 Jan;65(1):489-93 PMID: 1702163
  4. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein.
    J Virol. 1991 Apr;65(4):2047-55 PMID: 1900540
  5. gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains.
    J Virol. 1991 Jul;65(7):3797-803 PMID: 2041094
  6. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing.
    Virology. 1991 Sep;184(1):319-29 PMID: 1871974
  7. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody.
    J Virol. 1991 Nov;65(11):6188-93 PMID: 1717717
  8. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120.
    Science. 1991 Oct 4;254(5028):105-8 PMID: 1718036
  9. Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.
    Virology. 1991 Nov;185(1):72-9 PMID: 1718090
  10. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
    Science. 1984 May 4;224(4648):497-500 PMID: 6200935
  11. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.
    Science. 1984 Aug 24;225(4664):840-2 PMID: 6206563
  12. Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site.
    J Immunol. 1992 Jul 15;149(2):649-54 PMID: 1378074
  13. Discontinuous epitopes on gp120 important in HIV-1 neutralization.
    AIDS Res Hum Retroviruses. 1992 Aug;8(8):1337-9 PMID: 1281654
  14. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.
    J Immunol. 1993 Jan 15;150(2):635-43 PMID: 7678279
  15. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.
    J Virol. 1993 Feb;67(2):863-75 PMID: 7678308
  16. Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals.
    J Virol. 1993 Feb;67(2):953-60 PMID: 7678311
  17. Antibody epitopes sensitive to the state of human immunodeficiency virus type 1 gp41 oligomerization map to a putative alpha-helical region.
    AIDS Res Hum Retroviruses. 1992 Dec;8(12):2055-62 PMID: 1283526
  18. Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein.
    Virology. 1993 Mar;193(1):510-4 PMID: 8438588
  19. Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein.
    AIDS Res Hum Retroviruses. 1993 Jul;9(7):589-94 PMID: 8369163
  20. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
    J Virol. 1994 May;68(5):3015-26 PMID: 7512157
  21. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.
    Science. 1985 May 31;228(4703):1091-4 PMID: 2986290
  22. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.
    Nature. 1985 Jul 4-10;316(6023):69-72 PMID: 2989706
  23. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.
    Nature. 1985 Jul 4-10;316(6023):72-4 PMID: 2989707
  24. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.
    Science. 1985 Sep 27;229(4720):1402-5 PMID: 2994223
  25. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
    Science. 1986 Jan 24;231(4736):382-5 PMID: 3001934
  26. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.
    Science. 1986 Jul 11;233(4760):209-12 PMID: 3014647
  27. Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.
    Proc Natl Acad Sci U S A. 1986 Sep;83(18):7023-7 PMID: 3018753
  28. HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.
    Science. 1986 Dec 12;234(4782):1392-5 PMID: 2431482
  29. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.
    Annu Rev Biochem. 1987;56:365-94 PMID: 3304138
  30. Monoclonal antibodies localize events in the folding, assembly, and intracellular transport of the influenza virus hemagglutinin glycoprotein.
    Cell. 1988 Mar 25;52(6):843-52 PMID: 2450677
  31. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.
    Proc Natl Acad Sci U S A. 1988 May;85(9):3198-202 PMID: 2452447
  32. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.
    J Virol. 1988 Jun;62(6):2107-14 PMID: 2452899
  33. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.
    Proc Natl Acad Sci U S A. 1988 Jun;85(12):4478-82 PMID: 2454471
  34. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity.
    J Virol. 1988 Oct;62(10):3779-88 PMID: 3047430
  35. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.
    J Virol. 1988 Nov;62(11):4195-200 PMID: 2845130
  36. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.
    J Virol. 1989 Jun;63(6):2674-9 PMID: 2786089
  37. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
    Proc Natl Acad Sci U S A. 1989 Sep;86(17):6768-72 PMID: 2771954
  38. Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV.
    Virology. 1989 Sep;172(1):367-9 PMID: 2672564
  39. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
    Proc Natl Acad Sci U S A. 1990 Jan;87(2):648-52 PMID: 2300552
  40. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles.
    J Virol. 1990 Nov;64(11):5674-7 PMID: 2214033
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1994-11-22
Pages
11699-703
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC45299
Subset
IM
Grants
NIAID NIH HHS · R01-AI-35383 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]